- ¥3bn
- ¥3bn
- ¥6bn
- 57
- 28
- 33
- 30
Annual cashflow statement for Medical Net, fiscal year end - May 31st, JPY millions except per share, conversion factor applied.
2021 May 31st | 2022 May 31st | 2023 May 31st | 2024 May 31st | 2025 May 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | — | JAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 254 | 539 | 251 | 153 | 25.2 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 81.4 | -80 | 142 | 159 | 86.6 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 31.5 | -146 | -26.1 | -246 | -269 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Taxes Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 392 | 343 | 429 | 120 | -80.9 |
Capital Expenditures | -13 | -2.17 | -20.6 | -32.8 | -132 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -75 | -353 | -41.7 | -253 | -128 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Sale of Intangible Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -88 | -355 | -62.4 | -285 | -260 |
Financing Cash Flow Items | — | 1.05 | 0.239 | -0.002 | -0.025 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -34 | 282 | -17.9 | 144 | 219 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 273 | 260 | 385 | -5.64 | -104 |